Language
English
Publication Date
1-1-2022
Journal
PLoS One
DOI
10.1371/journal.pone.0269387
PMID
35653405
PMCID
PMC9162303
PubMedCentral® Posted Date
6-2-2022
PubMedCentral® Full Text Version
Post-print
Abstract
Background: The single patient (n-of-1) trial can be used to resolve therapeutic uncertainty for the individual patient. Treatment alternatives are systematically tested against each other, generating patient-specific data used to inform an individualized treatment plan. We hypothesize that clinical decisions informed by n-of-1 trials improve patient outcomes compared to usual care. Our objective was to provide an overview of the clinical trial evidence on the effect of n-of-1 trials on clinical outcomes.
Methods: A systematic search of medical databases, trial registries, and gray literature was performed to identify trials assessing clinical outcomes in a group of patients undergoing an n-of-1 trial compared to those receiving usual care for any clinical condition. We abstracted elements related to study design and results and assessed risk of bias for both the overall randomized trials and the n-of-1 trials. The review was registered on PROSPERO. (CRD: 42020166490).
Findings: Twelve randomized trials of the n-of-1 approach were identified in conditions spanning chronic pain, osteoarthritis, chronic irreversible airflow limitation, attention-deficit hyperactivity disorder, hyperlipidemia, atrial fibrillation, statin intolerance, and hypertension. One trial showed a statistically significant benefit in the primary outcome. Only one reached the pre-specified sample size target. Secondary outcomes showed modest benefits, including decreasing medication use, fewer atrial fibrillation episodes, and improved patient satisfaction.
Interpretation: Very few trials have been undertaken to assess the effectiveness of n-of-1 trials in improving clinical outcomes, and most trials were underpowered for the primary outcome. Barriers to enrollment and retention in these trials should be explored, as well-powered randomized trials are needed to clarify the clinical impact of n-of-1 trials and assess their utility in clinical practice.
Keywords
Atrial Fibrillation, Bias, Humans, Publication Bias, Randomized Controlled Trials as Topic, Registries
Published Open-Access
yes
Recommended Citation
Samuel, Joyce P; Wootton, Susan H; Holder, Travis; et al., "A Scoping Review of Randomized Trials Assessing the Impact of N-of-1 Trials on Clinical Outcomes" (2022). Library Staff Publications. 94.
https://digitalcommons.library.tmc.edu/library_docs/94